Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
JULY 28, 2023
The selections feature topics ranging from a review of modifications to blood glucose monitoring systems and related patent protections, an examination of insulin price changes from 2012-2019, and a discussion of why a proposed federal bill that would ban government health care programs from using the quality-adjusted life-year is misguided.
Let's personalize your content